Growth Metrics

Stereotaxis (STXS) Current Leases (2019 - 2026)

Stereotaxis (STXS) reported Current Leases of $662000.0 for Q1 2026, up 12.59% year-over-year from $588000.0 in Q1 2025, and up 3.12% on a QoQ basis from $642000.0 in Q4 2025.

Stereotaxis (STXS) has 8 years of Current Leases data on file, last reported at $662000.0 in Q1 2026.

  • Quarterly Current Leases rose 12.59% year-over-year to $662000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $662000.0 (up 12.59% YoY) and the FY2025 annual result came in at $642000.0, up 12.63% from the prior year.
  • Current Leases improved to $662000.0 in Q1 2026 per STXS's latest filing, from $642000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $662000.0 in Q1 2026 and bottomed at $297000.0 in Q1 2022.
  • The 5-year median for Current Leases is $443000.0 (2024), against an average of $477941.2.
  • Peak annual rise in Current Leases reached 39.18% in 2022, while the deepest fall reached 82.88% in 2022.
  • Tracing STXS's Current Leases over 5 years: stood at $373000.0 in 2022, then increased by 14.75% to $428000.0 in 2023, then soared by 33.18% to $570000.0 in 2024, then advanced by 12.63% to $642000.0 in 2025, then climbed by 3.12% to $662000.0 in 2026.
  • Per Business Quant, the three latest STXS Current Leases figures stand at $662000.0 (Q1 2026), $642000.0 (Q4 2025), and $623000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 29.23 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 21.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn 662,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 662,000.00
Dec 31, 2025 642,000.00
Sep 30, 2025 623,000.00
Jun 30, 2025 605,000.00
Mar 31, 2025 588,000.00
Dec 31, 2024 570,000.00
Sep 30, 2024 552,000.00
Jun 30, 2024 458,000.00
Mar 31, 2024 443,000.00
Dec 31, 2023 428,000.00
Sep 30, 2023 413,000.00
Jun 30, 2023 399,000.00
Mar 31, 2023 385,000.00
Dec 31, 2022 373,000.00
Sep 30, 2022 359,000.00
Jun 30, 2022 328,000.00
Mar 31, 2022 297,000.00
Dec 31, 2021 268,000.00
Sep 30, 2021 654,611.00
Jun 30, 2021 1.17 Mn
Mar 31, 2021 1.73 Mn
Dec 31, 2020 2.29 Mn
Sep 30, 2020 2.28 Mn
Jun 30, 2020 2.27 Mn
Mar 31, 2020 2.26 Mn
Dec 31, 2019 2.25 Mn
Sep 30, 2019 2.24 Mn
Jun 30, 2019 2.22 Mn
Mar 31, 2019 2.16 Mn